In a study commenced in 2023 on a sample of 650 patients (2), work is underway to train an artificial intelligence model that is intended to estimate the risk of lung cancer based on the results of computed tomography and the results of markers in blood tests in relation to microRNA and C-reactive protein. The gene discussed is CRP; the disease is lung carcinoma.